Author Guidelines

Author Guidelines and Submission Requirements

Journal of Public Health and Pharmacy

Authors must prepare their submission using the official JPHP Title Page and Anonymized Main Document templates. Both files must be submitted separately. Authors must replace every bracketed placeholder and remove all instructional text, comments, examples, and highlights before submission. Manuscripts that do not comply with these requirements may be returned for technical correction before editorial evaluation.
Required Submission Files

Upload the following files through the journal's online submission system:

FILE 1
Title Page
Contains author-identifying information, manuscript metadata, corresponding-author details, optional ORCID iDs, acknowledgments, and publication declarations.
Open Title Page Template
FILE 2
Anonymized Main Document
Contains the complete scholarly content without author names, affiliations, email addresses, acknowledgments, or other identifying information.
Open Main Document Template
FILE 3
Similarity Report
The maximum similarity index is 20%. The editorial team evaluates the source, location, extent, pattern, and context of similarity during initial screening.
File Separation for Double-Blind Review
Include in the Title Page
Author names, affiliations, ORCID iDs when supplied, corresponding-author details, acknowledgments, author contributions, funding information, conflicts of interest, ethics information, data availability, generative AI declarations, and other identifying statements.
Exclude from the Main Document
Author names, affiliations, ORCID iDs, email addresses, acknowledgments, author-contribution statements, identifying funding information, institution-identifying file properties, comments, tracked changes, and other information that may reveal authorship.
Article Types

JPHP accepts Original Research Articles and Review Articles that make a clear contribution to public health, pharmacy, pharmaceutical sciences, clinical pharmacy, community pharmacy, pharmacoepidemiology, medication safety, pharmacotherapy, health promotion, disease prevention, health policy, healthcare systems, health services, or related disciplines. All submissions must demonstrate originality, methodological rigor, research integrity, ethical compliance, analytical relevance, and adherence to applicable reporting guidelines.

Original Research Articles
Review Articles
Title Page Requirements
Article Information
State the article type, complete article title, and a short title of no more than 50 characters, including spaces.
Authors and Affiliations
List all authors in the agreed publication order. Use superscript numerals to connect each author with the correct department, faculty, institution, city, and country. Identify the corresponding author clearly.
ORCID iDs: Recommended, Not Mandatory
Authors are strongly encouraged to provide a valid ORCID iD. ORCID is not mandatory for submission, and its absence alone will not result in technical correction or rejection. When supplied, the ORCID iD must belong to the named author and use the complete https://orcid.org/ URL.
Corresponding Author
Provide the full name, institutional affiliation, complete postal address, active email address, and an optional telephone number with country code.
Manuscript Information
Report the word counts for the abstract and main text, together with the numbers of references, tables, figures, and supplementary files.
Declarations in the Title Page
Author Contributions
Describe each author's contribution using appropriate CRediT roles and confirm approval and accountability.
Conflicts of Interest
Declare all financial and nonfinancial interests, or state that no conflicts of interest exist.
Funding
State the funder, grant number, and funder's role, or clearly state that no specific funding was received.
Ethics Approval and Consent
Provide the ethics committee name, approval number, approval date, and consent procedure, or explain why approval was not required.
Consent for Publication
Required when an individual may be identified through text, images, audio, video, quotations, or case details.
Data Availability
State where data may be accessed, applicable restrictions, and the repository or persistent identifier where available.
Generative AI Declaration
Disclose the tool name and version, purpose of use, and the authors' verification and responsibility for the final content.
Acknowledgments
Recognize contributors who do not meet authorship criteria and confirm their agreement to be named.
Anonymized Main Document
Structured Abstract

State essential information only. Do not include citations, undefined abbreviations, tables, figures, or author-identifying details.

Introduction
Methods
Results
Conclusion
Keywords: Provide three to six relevant standardized terms separated by semicolons.
Main Document Structure
INTRODUCTION
Explain the public-health or pharmacy problem, summarize relevant evidence, identify the unresolved gap, establish the study rationale, and conclude with a clear objective or hypothesis.
METHODS
Report sufficient methodological detail for scientific evaluation and replication. Apply the reporting guideline appropriate to the study design.
RESULTS
Present findings in the same order as the objectives and methods. Report denominators, effect estimates, confidence intervals, and relevant statistical measures. Avoid unnecessary duplication among text, tables, and figures.
DISCUSSION
Interpret the findings critically, compare them with relevant evidence, explain plausible mechanisms, discuss strengths and limitations, and avoid overstating causal, clinical, pharmaceutical, or public-health implications.
CONCLUSION
Directly address the study objective, reflect the magnitude and certainty of the findings, and avoid introducing new information.
ETHICS AND DATA STATEMENTS
Retain anonymized ethics approval, informed-consent, data-availability, and trial or protocol registration information.
REFERENCES
Use numbered citations in order of first appearance and format all references consistently in Vancouver style.
FIGURE LEGENDS
List each figure legend separately and define all symbols, abbreviations, panels, and statistical annotations.
SUPPLEMENTARY MATERIAL
List supplementary tables, figures, questionnaires, protocols, analytical code, or datasets in citation order, or remove the section when not applicable.
Recommended Methods Subsections
Study Design
Study design, conceptual framework, and analytical approach
Setting and Study Period
Study location, institutional context, geographic scope, and dates
Participants, Sample, or Data Sources
Eligibility, sampling, recruitment, sample-size basis, and analytical sample
Variables and Measurement Instruments
Outcomes, exposures, covariates, instruments, validity, reliability, and operational definitions
Data Collection and Quality Control
Procedures, training, calibration, missing-data management, and quality assurance
Statistical or Qualitative Analysis
Software, version, analytical methods, effect estimates, intervals, thresholds, and sensitivity analyses
Ethical Considerations
Ethical framework, approval, consent, confidentiality safeguards, and registration
Discussion Subsections
Principal Findings
Comparison With Existing Evidence
Strengths and Limitations
Public-Health and Pharmacy Implications
Reporting Guidelines

Authors must apply the reporting guideline appropriate to the study design. The completed checklist and applicable flow diagram may be requested during technical screening, editorial assessment, or revision.

STROBE
Observational studies
CONSORT
Randomized controlled trials
PRISMA
Systematic reviews and meta-analyses
PRISMA-ScR
Scoping reviews
COREQ or SRQR
Qualitative studies
CHEERS
Health-economic and pharmacoeconomic evaluations

View Reporting Guidelines

References, Tables, Figures, and Supplementary Files
Number citations in order of first appearance and apply Vancouver style consistently. Verify all bibliographic details and include a DOI or stable URL where available. Number tables and figures in the order first cited, use concise descriptive titles, define abbreviations and statistical annotations, and provide publication-quality figures with complete legends. List supplementary files in citation order.
Final Submission Check
•
Replace every bracketed placeholder in both templates.
•
Delete all instructional text, comments, highlights, examples, and sample wording before submission.
•
Submit the Title Page separately from the Anonymized Main Document.
•
Remove author-identifying information, comments, tracked changes, hidden content, and file properties from the Main Document.
•
Confirm that the Similarity Report corresponds to the final submitted manuscript and does not exceed 20%.
•
When an ORCID iD is provided, confirm that it belongs to the correct author and is entered as the complete https://orcid.org/ URL.
•
Confirm that all declarations, ethics statements, data information, references, tables, figures, supplementary files, and OJS metadata are complete and mutually consistent.
Manuscripts that do not use the official templates, contain incomplete declarations, fail to protect double-blind review, or do not comply with the JPHP requirements may be returned for technical correction before editorial evaluation.